Resistance to β-lactam antibiotics through β-lactamase production by Enterobacteriaceae continues to burden the health-care sector worldwide. Traditional methods for detection of β-lactamases are time-consuming and labor-intensive and newer methods with varying capabilities continue to be developed. The objective of this study was to develop a multiplex PCR (M-PCR) system for the detection of bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes and to apply it in clinical Klebsiella pneumoniae and Escherichia coli strains. To do this, we used group-specific PCR primers in singleplex reactions followed by optimization into multiplex reactions. Specificity and sensitivity of the M-PCR were then evaluated using 58 reference strains before its application to detect bla group genes in 203 clinical Enterobacteriaceae strains. PCR amplicons were sequenced to determine the β-lactamase subtypes. The M-PCR system exhibited 100% specificity and sensitivity. In all, 83.7% of K. pneumoniae and 89.8% of E. coli clinical strains harbored bla group genes with 46.9%, 40.1%, 15.0%, 21.1% and 6.1% of K. pneumoniae having bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes, respectively, whereas 12.2%, 77.6%, 22.4%, 36.7% and 8.2% of E. coli had bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes, respectively. Bla SHV-1 , bla SHV-11 , bla SHV-27 , bla SHV-33 , bla SHV-144 , bla TEM-1 , bla TEM-135 , bla OXA-1 , bla CTX-M-3 , bla CTX-M-9 , bla CTX-M-14 , bla CTX-M-15 , bla CTX-M-27 , bla CTX-M-55 , bla CTX-M-65 and bla CTX-M-104 were detected. In conclusion, the M-PCR system was efficient and versatile with an advantage of simultaneously detecting all the targeted bla group genes. Hence, it is a potential candidate for developing M-PCR kits for the screening of these genes for clinical or epidemiological purposes.
INTRODUCTION
With the discovery that microorganisms naturally produce substances that inhibit other microorganisms came the possibility of effectively treating infectious diseases. 1 However, soon after, cases of resistance began to emerge. 2 The β-lactam group of antibiotics is one of the worst affected by antimicrobial resistance through a variety of mechanisms. 3 β-lactamases including broad-and extended-spectrum β-lactamases (ESBLs) have been reported predominantly in Enterobacteriaceae, especially Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli). [4] [5] [6] Most extended-spectrum β-lactamases fall into three genotypes: TEM, SHV and CTX-M 7 with hundreds of variants of these gene families having emerged and disseminated widely requiring concerted efforts to effectively control. 6, 8 An example is the 4130 allelic variants of CTX-M (Lahey Clinic website: http://www.lahey.org/Studies/other.asp#table1). 9 Other β-lactamases including AmpC, carbapenemases and OXA-type enzymes have also been consistently reported to cause antibiotic resistance in Enterobacteriaceae. 10, 11 OXA-1-like enzymes are sometimes harbored alongside the CTX-M group in K. pneumoniae and E. coli, 10 whereas the OXA-10 derivatives (OXA-11, -14, -16, -17 and -19) exhibiting ESBL activity, and carbapenem-hydrolyzing class D β-lactamases (CHDLs, e.g., OXA-23, -24/40, -48, -51 and -58), are commonly found in Pseudomonas aeruginosa and Acinetobacter baumannii, respectively. [11] [12] [13] Notably, carbapenemases, especially metallo-β-lactamases, present a far greater risk of treatment failure with the currently available drugs in clinical practice. However, by and large, the prevalence of these enzymes in clinical Enterobacteriaceae, especially K. pneumoniae and E. coli in China is comparatively lower compared with that of bla SHV -, bla TEM -, bla CTX-M-1 -, bla CTX-M-9 -or bla OXA-1 -encoded enzymes. 14 A recent study in Central China has reported that the prevalence of carbapenem resistance in Enterobacteriaceae was 1%. 15 With the current overall concern about carbapenemases, it is beneficial to carefully monitor and control any potential spread of carbapenemase-producing bacterial strains in China and other countries in this region. 16 The phenotypic screening and detection of β-lactamase (bla) genes are routinely carried out through tedious culture-based methods, whereas their definitive confirmation in Enterobacteriaceae and other bacteria is achieved largely by molecular methods. 17 As the current subtypes and variants are continuously evolving and disseminating both geographically and among the various bacterial species, 7 growing numbers of Enterobacteriaceae, especially K. pneumoniae and E. coli from clinical sources tend to harbor multiple β-lactamases and exhibit multiresistance to the various β-lactams. Consequently, existing efforts geared toward sustained and continuous development of new accurate and rapid molecular methods with the ability to simultaneously detect multiple bla genes in single and/or mixed bacterial strains must be sustained.
Different workers have developed multiplex PCR (M-PCR) assays that detect different bla genes or combinations of bla genes in Enterobacteriaceae. For instance, two assays were previously constructed including one that detects the five phylogenetic groups of the bla CTX-M genotype, 18 and another that targets the bla TEM , bla SHV and bla CTX-M genotypes. 19 Recently, a group of workers developed six M-PCR assays that can detect most of the bla genes in different combinations. 17 Others have constructed M-PCR assays for detecting carbapenemase 20 and AmpC 21 genes. These assays vary in their achievable capabilities in detecting the different bla group genes. Evidently, the currently available M-PCR assays lack the ability to detect bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes simultaneously in a single reaction. As these are the most commonly encountered bla genes in this region, we sought to develop an M-PCR system that can detect these five bla group genes concurrently in a single reaction. We report a versatile and effective new system and its application in detecting these bla group genes in clinical Enterobacteriaceae strains from two hospitals in Harbin area of North East China.
MATERIALS AND METHODS

Bacterial strains
K. pneumoniae (n = 45), E. coli (n = 11) and Enterobacter cloacae (n = 2) were used as reference strains in the optimization and evaluation of the M-PCR system. The distribution of bla group genes in these reference strains had been determined previously by at least two singleplex PCR assays with gene-specific primers and DNA sequencing. Another 203 randomly chosen non-repetitive clinical K. pneumoniae (n = 147), E. coli (n = 49), Enterobacter cloacae (n = 5) and Serratia liquefaciens (n = 2) strains previously obtained from patients aged 6 days to 85 years from two hospitals in Harbin area of North East China were used in the application of the developed M-PCR system to detect bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes. These isolates were recovered from urine, stool, blood, sputum, throat swab, pus and aspirate specimens, and were identified using API 20E identification system (BioMérieux, Lyon, France). Identified clinical isolates were stored in 50% glycerol at − 85°C until used.
Preparation of template DNA
DNA template was prepared according to a previously reported method 22 with a slight modification. A single colony of each strain was subcultured in 2 ml of Luria-Bertani broth (Oxoid, Hampshire, UK) for 16 h at 37°C with shaking at 200 r.p.m. Cells from 1.5 ml of this culture were harvested by centrifugation at 13 000 g for 10 min and the pellet was resuspended in 500 μl of double-distilled water. The cells were then lysed by heating at 99°C for 15 min, and cellular debris removed by centrifugation at 13 000 g for 10 min. The supernatant containing the harvested DNA was collected and stored at − 20°C until used in the PCR experiments.
Development, optimization and evaluation of the M-PCR system
Group-specific oligonucleotide primers for bla CTX-M-1 and bla CTX-M-9 group genes were designed using the Primer3 software 23 while the primers specific for bla TEM , bla SHV and bla OXA-1 group genes were obtained from literature (see Table 1 ). All the primers were manufactured and supplied by Sangon Biotech (Shanghai, China). Initially, the group-specific primers were tested in singleplex PCR reactions under the following reaction conditions: initial denaturation at 94°C for 10 min; 30 cycles of denaturation at 94°C for 30 s, annealing Table 1 Group-specific primers used in this study Perez et al. 13 Singleplex and multiplex PCR and sequencing
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Perez et al. 13 Singleplex and multiplex PCR and sequencing (at 60.1°C, bla TEM ; 58°C, bla SHV ; 60.1°C, bla OXA-1 ; 57.8°C, bla CTX-M-1 ; 57°C, bla CTX-M-9 ) for 35 s and extension at 72°C for 1 min; and final extension at 72°C for 9 min. The amount of each primer and DNA lysate for the 50 μl initial singleplex PCR reaction were 5 nmol and 2 μl, respectively. The primers were then added together in single reactions to develop and optimize the M-PCR system. Reaction conditions and amounts of reactants were adjusted appropriately to achieve optimal amplification of all the five bla genes. Annealing temperature gradient PCR was used to determine the optimum annealing temperature. Upon optimization, the PCR conditions used in all the subsequent singleplex and multiplex reactions were: initial denaturation at 94°C for 10 min; 30 cycles of denaturation at 94°C for 30 s, annealing at 61°C for 35 s and extension at 72°C for 1 min; and final extension at 72°C for 9 min. Primer concentrations of 5 nmol for M-TEM-F and R, M-SHV-F and R, M-OXA-1-F and R and M-CTX-M-1-F and R; and 10 nmol for M-CTX-M-9-F and R were used (Table 1) . For each 50 μl reaction, 5 μl DNA lysate and 25 μl 2 × Taq Master Mix (Sangon Biotech, Shanghai, China) were added. DNA lysates from each of the 58 reference Enterobacteriaceae strains were then used in both singleplex PCR and M-PCR experiments to evaluate and verify the specificity and sensitivity of the newly developed multiplex system as shown in Table 2 . Stability and efficiency of the system against varying genomic environments was further tested by mixing DNA lysates from same or different Enterobacteriaceae species. PCR products were separated in a 2.5% agarose gel at 80 V for 1 h 30 min and visualized in UV light after staining with ethidium bromide for 3-5 min. A 100 bp DNA ladder (Tiangen Biotech, Beijing, China) was used as a molecular size marker. All PCR experiments were carried out using Bio Rad T100 Thermal cycler (Bio Rad, Singapore city, Singapore).
Application of the M-PCR system in detecting bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes in clinical Enterobacteriaceae strains
The newly developed M-PCR system was applied in the multiplex PCR detection of bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 group genes in 203 clinical Enterobacteriaceae strains obtained from two hospitals in Harbin area of North East China including 147 K. pneumoniae, 49 E. coli, 5 E. cloacae and 2 S. liquefaciens clinical strains.
Confirmation of the M-PCR system by direct DNA sequencing of the PCR products
To further ascertain the efficiency of the new M-PCR system, each of the PCR products from the strains that tested positive for the bla group genes were subjected to direct bidirectional DNA sequencing using either the M-PCR primers or sequencing primers 24, 25 (shown in Table 1 ). The DNA sequencing data were compared with known bla allele sequences (Lahey Clinic website: http://www.lahey.org/Studies/other.asp#table1) by multiple-sequence alignment using the ClustalW2 online program. The gene sequences detected in this study have been deposited with GenBank under accession numbers KP698217-KP698229 and KR338940-KR338951. 
Antibiotic sensitivity testing
Ethical considerations
This study complied with current ethical stipulations.
RESULTS
Development and optimization of the M-PCR system
Singleplex PCR reactions were initially carried out at different annealing temperatures designated for each primer pair (Table 1) yielding distinct PCR products (bla TEM , 800 bp; bla SHV , 713 bp; bla CTX-M-1 , 655 bp; bla OXA-1 , 564 bp; and bla CTX-M-9 , 518 bp) in representative reference Enterobacteriaceae strains (Figure 1a ). M-PCR at the optimized annealing temperature (61.0°C) simultaneously amplified all the five bla group genes in the reference strains harboring single or multiple bla genes (Figure 1b) . Distinct PCR products were also obtained after DNA lysates from two or three different reference strains belonging to the same or different species were mixed together before M-PCR amplification of the five bla group genes ( Figure 1c ). These results demonstrate that the M-PCR system can effectively detect all the five bla group genes in pure or mixed genomic environments in clinical specimens.
Evaluation of specificity and sensitivity of the multiplex system using reference strains The newly developed M-PCR system was efficient in detecting the bla group genes. Using singleplex PCR to detect the presence of bla group genes, 53 of the 58 reference Enterobacteriaceae were found to possess at least 1 bla group gene. Of them, 26 were found to contain 42 bla group genes. The M-PCR amplification of total DNA lysates from the each 58 reference strains was also carried out. There was 100% agreement for all the genes and reference strains tested. Specificity and sensitivity of the M-PCR, calculated according to the following formula: {specificity = (D/C+D × 100); (sensitivity = A/A+B × 100), where A is true positive, B is false negative, C is false positive and Specificity and sensitivity were calculated based on a previously used formula. 27 a Specificity = D/C+D ×100. b Sensitivity = A/A+B × 100.
D is true negative}, 27 were both determined to be 100% ( (Table 3 ). Only one of the five E. cloacae harbored a bla group gene (bla TEM ), whereas the two S. liquefaciens strains possessed none of the bla group genes.
Confirmation of the M-PCR system by direct DNA sequencing of the PCR products All the results of the M-PCR system coincided with the DNA sequencing results and their distribution in the clinical strains is summarized in Table 4 . Briefly, of the 203 studied clinical strains, the CTX-M subtypes were detected in 40.4%, whereas TEM, SHV and OXA-1 subtypes were seen in 47.9%, 38.4% and 6.4%, respectively. Forty-nine percent (n = 24) of the 49 strains with two subtypes had CTX-M14. Five SHV subtypes: SHV-1 (n = 53), SHV-11 (n = 11), SHV-27 (n = 2), SHV-33 (n = 2) and SHV-144 (n = 1) were detected in clinical K. pneumoniae, whereas only one subtype (SHV-1, n = 6) was seen in clinical E. coli strains. All the strains with OXA-1like subtypes (9 K. pneumoniae and 4 E. coli) harbored the OXA-1 enzyme. One and two clinical E. coli strains harbored bla CTX-M-1 and bla CTX-M-9 genotypes exhibiting uniform resistance rates of 100% and 50%, respectively, to CTX, CAZ, CRO and ATM. The only one E. cloacae with bla TEM genotype was sensitive to all the CTX, CAZ and ATM but not CRO, whereas both the S. liquefaciens strains were sensitive to the four antibiotics. Clinical strains with bla SHV and bla TEM genotypes alone exhibited relatively low resistance to the four drugs, whereas in combination with bla CTX-M group genes, their resistance rates against these antibiotics rose markedly. Contrastingly, as shown in Table 3 , strains with bla CTX-M-1 genotypes showed 100% or near-100% resistance rates to the third-generation cephalosporins, regardless of the pattern they took while strains with bla CTX-M-9 alone exhibited relatively low resistance rate to CAZ, but in combination with bla CTX-M-1 , their resistance to CAZ rose markedly.
Resistance to three or more β-lactam agents was associated with specific gene type and number As shown in Figure 3 , there was a positive correlation between the number of bla group genes harbored by the clinical strains and the number of antibiotics to which they exhibited resistance (by 
The bla genotypes found in both K. pneumoniae and E. coli clinical strains are indicated in bold.
Spearman's rank correlation; r s = 0.525, Po0.05). Resistance to three or more agents was associated with presence of two bla group genes. Specifically, analysis of our data revealed that carriage of bla TEM or bla CTX-M-1 group genes correlated positively with resistance to three or more antibiotics (P = 0.001; Table 5 ). Many strains harboring bla TEM group genes also coharbored bla CTX-M-1 and bla CTX-M-9 group genes (see Table 3 ). This positive association between bla TEM and/or bla CTX-M-1 group gene(s) and the resistance to three or more antibiotics was further confirmed by multiple logistic regression analysis (see Table 6 ).
DISCUSSION
The dissemination of β-lactamase enzymes, especially ESBLs, among the members of Enterobacteriaceae family and other Gram-negative bacteria has been on the rise in the past two to three decades. 28 It creates a public health problem that requires clinical microbiology laboratories to carry out β-lactamase identification and typing. In most clinical settings, especially in the developing countries, the screening and detection of β-lactamases in bacteria has, for the most part, been based on the agar disk tests (such as the disk diffusion tests) and isoelectric focusing. These methods are tedious, time consuming and replete with a myriad of challenges. 17, 29 Clinical and reference microbiology laboratories, therefore, must use alternative and/or additional techniques that present rapid, reliable and reproducible test outcomes. Consequently, it is even more beneficial to detect accurately the presence or potential expression of these enzymes in bacteria on large scale. A number of molecular methods including oligotyping, PCR-single-strand conformation polymorphism, PCRrestriction fragment length polymorphism and ligase chain reaction have been used in the identification of ESBL genes. 29 However, most of these techniques have the disadvantage of detecting only a single gene at a time. In contrast, M-PCR has been used to amplify multiple genes simultaneously in a single test. 29 In this way, it has become a more efficient and applicable option to concurrently detect multiple bla subtypes in single reactions. In 2005, Woodford et al. 18 developed an M-PCR assay that could detect each of the five phylogenetic groups of bla CTX-M genotype. However, these assays would fail to encompass the detection of the bla TEM and bla SHV genotypes. In 2007, another M-PCR system was described that could detect the bla TEM , bla SHV and bla CTX-M genotypes using universal PCR primers for the bla CTX-M group. 19 That system requires extra singleplex assays to identify the five groups of the bla CTX-M genotype. Three multiplex assays were later described by Woodford in 2010 30 for the detection of the five CTX-M groups, metallo-β-lactamases and OXA-type carbapenemases. A clearly more comprehensive work to achieve this was carried out by Dallenne et al., 17 in 2010. However, their work relied on two separate assays to screen for the presence bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 genes. Unlike these and most of the currently available assays, our M-PCR system provides the advantage of detecting the targeted five bla group genes (bla SHV , bla TEM , bla CTX-M-1 , bla CTX-M-9 and bla OXA-1 ) simultaneously in the clinical strains with high specificity and sensitivity (see Table 2 ). Thus, it could be a useful tool in China and other countries where bla CTX-M-1 and bla CTX-M-9 gene clusters, among others, have been reported to be on the rise. 9, [31] [32] [33] For instance, these enzymes, with varying prevalence rates, have also been reported in many countries in the Asia-Pacific region. 34 Although CTX-M group enzymes emerged later compared with TEM and SHV types, they have spread worldwide and specific subgroups have been localized in different geographic regions. 35, 36 Among them, CTX-M-9 group β-lactamases (CTX-M-14 subtype) are the most widespread in China followed by CTX-M-1 group (CTX-M-3). [36] [37] [38] The occurrence of these enzymes vary from country to country, with Japan having the lowest bla gene prevalence rates among the neighboring countries. 34, [36] [37] [38] Owing to their very low prevalence rates in China, the scope of application and use this M-PCR system does not include bla CTX-M-2 , bla CTX-M-8 and/or bla CTX-M-25 group genes.
Our M-PCR data show that among the K. pneumoniae clinical strains, bla SHV (46.9%) and bla TEM (40.1%) group genes were the most prevalent in this region followed by group genes bla CTX-M-9 (21.1%), bla CTX-M-1 (15.0%) and bla OXA-1 (6.1%). In E. coli, bla TEM group (77.6%) was the most prevalent followed by bla CTX-M-9 Table 4 The distribution of β-lactamase subtypes among the clinical K. pneumoniae and E. coli strains M-PCR products from 123 K. pneumoniae and 44 E. coli clinical strains were subjected to direct DNA sequencing. Figure 3 Correlation between the number of bla group genes and the number of antibiotics to which the strains are resistant. The X axis represents the resistance phenotype (number of agents), whereas the Y axis represents mean and 95% CI of the number of bla genes in each group (by Spearman's rank correlation analysis; r s = 0.525; Po0.05). Table 5 Relationship between bla genes and resistance to three or more antibiotics in the 203 clinical strains (by Genotypes found in both K. pneumoniae and E. coli strains are indicated in bold.
(36.7%), bla CTX-M-1 (22.4%), bla SHV (12.2%) and bla OXA-1 (8.2%) group genes. Although the prevalence of bla SHV (46.9%) in K. pneumoniae in this region appear to be unusually lower compared with previously reported levels such as in Korea (97%) and Brazil (55.8%), 39 they particularly coincide with findings of a previous study elsewhere in China (45.8%). 39 Strains with SHV and TEM genotypes alone exhibited relatively low resistance to the third-generation cephalosporins and monobactam, whereas in combination with bla CTX-M group genes, their resistance rates against these antibiotics rose markedly. Contrastingly, strains with bla CTX-M-1 showed high resistance rates to these β-lactams. Strains with bla CTX-M-9 group gene alone exhibited relatively low resistance rate to CAZ, but in combination with bla CTX-M-1 , resistance to CAZ rose markedly. There could be a possibility that bla CTX-M-1 group genes in this region may have mediated resistance to both CTX and CAZ strains. On the other hand, the lower resistance rates to third-generation cephalosporins by clinical strains harboring bla SHV or bla TEM alone indicate that most of the SHV or TEM enzymes did not confer extended-spectrum β-lactamase activity. However, there exists some reports that tend to suggest that TEM-1 may also contribute to the ESBL trait in concert with other β-lactamases. 7, 40 Upon DNA sequencing of PCR products from all strains with bla group genes, the distribution of the β-lactamase subtypes corresponded with the M-PCR results. CTX-M-14 and CTX-M-3 were the most prevalent among the ESBL-producing clinical K. pneumoniae and E. coli strains. Besides CTX-M-14, other CTX-M-9 group subtypes included CTX-M-9 and CTX-M-104 in clinical K. pneumoniae and CTX-M-65, and CTX-M-27 in E. coli. In the CTX-M-1 group, subtypes other than CTX-M-3 included CTX-M-15, CTX-M-55 in K. pneumoniae, and CTX-M-55, CTX-M-15 and CTX-64 in E. coli. These results are in agreement with previous reports that have projected CTX-14 to be the most common in different parts of China followed by CTX-M-3. [36] [37] [38] 41 Our data also indicate that the CTX-M-15 enzyme, which has been reported to have a worldwide distribution, especially in E. coli and with a great potential for epidemics, 42 is also available in this region. The four strains of K. pneumoniae possessing ESBL-SHV enzymes (SHV-27 and SHV-33) co-harbored CTX-M-14 with most of the rest carrying SHV-11 and SHV-1. The clinical E. coli strains did not harbor any ESBL-SHV enzymes. TEM-1 subtype was found in both K. pneumoniae (39.5%) and E. coli (77.6%) strains. Only one K. pneumoniae harbored a TEM-ESBL (TEM-135) subtype, which has also been reported in other parts of China. 43 As reported in other previous works, the OXA-1 subtypes were co-harbored along with other enzymes. 10 Statistical evaluation of our data revealed that bla TEM and bla CTX-M-1 group genes were positively associated with resistance to more than three β-lactams. These results consolidate a notion that the M-PCR system could highlight the association of specific bla group genes and the resistance to multiple β-lactam agents. That multiresistant strains may harbor large and easily transferrable genetic elements comprising bla and other genes is not uncommon. 44 The co-existence of multiple resistance genes in a single strain raises the likelihood of their dissemination to new strains with the diversity of their resistance further complicating their molecular detection and subsequent treatment.
CONCLUSION
In conclusion, this M-PCR system effectively detected the five major bla group genes simultaneously in a single PCR reaction in Enterobacteriaceae clinical strains. Further confirmation of the M-PCR results by DNA sequencing of PCR products is a proof of its efficiency.
By demonstrating high specificity and sensitivity in detecting the targeted group genes both with and without mixing template DNA from different strains, this system can be considered as a potential candidate for the development of M-PCR kits for the identification of these genes in clinical and epidemiology laboratory settings. Most of the K. pneumoniae (83.7%) and E. coli (89.8%) clinical strains in this study had 41 bla genes. Consequently, there is potential problem of resistance to multiple agents resulting from production of specific β-lactamases in this region. Hence, an efficient detection system would help enhance diagnosis, improve treatment decisions, guide antimicrobial stewardship and strengthen infection control programs in this region and elsewhere.
